bufuralol

This page covers all bufuralol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Multidrug resistance protein 1, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor.

Targets

Multidrug resistance protein 1, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor

Phase 2 pipeline (1)

• (+/-)-Bufuralol · Cardiovascular
  Bufuralol works by blocking the beta-2 adrenergic receptor, which helps to slow the heart rate and reduce blood pressure.

Patent intelligence

• bufuralol patent landscape — aggregated cliff calendar, attackable patents, originator estates